Skip to main content
Full access
Clinical Synthesis
Published Online: 13 April 2016

Innovative Psychological Treatments for Depression

Abstract

A number of high-intensity psychosocial interventions have been shown to be as efficacious as and more enduring than medications in the treatment of nonpsychotic depression. Moreover, there have been important advances in the development of strategies to facilitate the selection of the best treatment for a given patient with a depression diagnosis. However, the demand for services is too great to be met by conventional high-intensity approaches alone. Some of the most exciting work in recent years has focused on the development of low-intensity approaches that can benefit many people and do so cost-effectively.
The past several years have seen important innovations in the treatment of depression. We have learned more about established interventions (particularly with respect to how to select the best treatment for a given patient, i.e., personalized or individualized approaches), and novel interventions (or new uses for established interventions) have been developed and evaluated. Perhaps the most exciting developments have come in the area of low-intensity strategies that aim to deliver therapies with far shorter support time from the practitioner, such as computerized therapy and bibliotherapy (printed manuals). The evidence base for such approaches continues to develop, and there are suggestions that they yield outcomes equal to those of traditional so-called high-intensity psychotherapy approaches typically delivered as 12–20 one-hour sessions by an expert practitioner. We review these developments in turn.
We consider three types of relative outcomes (1). Efficacy, which refers to whether an intervention has a causal effect, can be inferred via clinical trials whenever a treatment is compared with a control group and the treatment is found to be better than its absence. Specificity refers to whether an intervention is more efficacious than the generic effects of simply going into treatment—such as the general effects of feeling listened to and receiving support, the mobilization of hope, and the establishment of a working alliance. Superiority refers to whether an intervention is actually better than alternative “active” interventions such as another talking therapy or medication. As we shall see, most of the existing psychosocial interventions are efficacious (their use is better than their absence), and some may be specific (they have active mechanisms that rise above the nonspecific benefits of simply going into treatment). Whether any one intervention is superior to another is an ongoing matter of contention (2), and allegiance effects loom large in individual comparisons (3). We also note that there is an asymmetry in the field; medications cannot be approved for sale unless they have demonstrated specificity (their effects must exceed those of placebo controls in order for them to be marketed), whereas it is perfectly reasonable for therapists to charge for psychosocial interventions that may provide little more than nonspecific support and the promise of confidentiality from a sympathetic listener (4). In fact, the major portion of the acute effects produced by interventions for depression are a consequence of these nonspecific processes (5), although, as we shall see, some of the cognitive and behavioral interventions have enduring effects, not found for medications, that last beyond the end of treatment (6).

Established High-Intensity Interventions

Cognitive-Behavioral Therapy (CBT)

Of the existing treatments for unipolar depression, CBT remains one of the best established. Although CBT has been labeled as a unitary approach, multiple minor modifications of the general model have been developed and evaluated. CBT has been shown to be as efficacious as antidepressant medications, and each of these treatments has been shown to be superior to placebo in the treatment of patients with more severe depressions (7). This finding was confirmed in a recent patient-level meta-analysis involving over 1,700 patients treated in randomized controlled trials (RCTs) comparing the two monotherapies (8). CBT has been criticized by some as lacking long-term follow-up; however, CBT has an enduring effect after treatment termination not found for antidepressant medications (9). There are indications that this enduring effect might even be superior to prior effects of continuing antidepressant medications with patients whose depression remitted (10). Adding CBT appears to produce a modest 10% increment in rates of recovery over medication alone, but this increment is heavily moderated; nonchronic patients with more severe depressions showed a rather large 30% increment when CBT was added, whereas nonchronic patients with less severe depressions did not need this addition, and chronic patients regardless of severity did not benefit from it (incremental benefits were negligible for each of these latter two groups) (11). DeRubeis and colleagues (12) have developed a novel strategy for generating algorithms that can identify the best treatment for a given patient. Application of this personalized advantage index (PAI) to a recent RCT indicated that about a quarter of the patients randomly assigned to each monotherapy (CBT or antidepressant medications) would have improved more if they had received the other treatment and that overall outcomes would have been improved by an amount equal to the advantage of antidepressant medications over placebo if each patient had received optimal treatment (12). The PAI can be applied to any treatment and could be used to improve the efficiency of health care delivery and to increase the power and specificity of tests of mechanism. However, this specialist high-intensity CBT approach is maximized when conducted according to a treatment manual and delivered by trained and competent practitioners who receive ongoing supervision (13). When delivered in such robust ways, CBT results in high efficacy in terms of recovery (14); however, results can be more disappointing when CBT is introduced without a focus on consistently delivered service. There is increasing interest in whether and how CBT can be delivered via low-intensity interventions such as through books (bibliotherapy) and online.

Behavioral Activation Therapy

Behavioral activation is a therapy that represents a partial return to the principles of behavioral medicine as developed in the 1960s and 1970s (15), and the model has been extended to include added concepts such as having the patient choose to do activities that he or she values, as well as activities that provide a sense of pleasure, achievement, and closeness to others. The model also emphasizes the importance of engaging in routine/mundane activities such as washing clothes, doing household chores, and performing self-care routines as a way to prevent further problems from developing. The focus is still on behavior more than on cognition, but the model instead emphasizes engagement with potential reinforcers in the environment. Avoidance is a key target for change. The model argues that when people are distressed it is a relief to them not to have to do their usual activities; however, the less people do, the worse they feel, and the worse they feel, the less they do, contributing to a vicious cycle of avoidance, which is the target for change. In a study conducted at its home institution, behavioral activation was found to be as efficacious as antidepressant medications and superior to both CBT and placebo among patients with more severe depressions (16) and as enduring as CBT (with each superior to prior antidepressant medications) following treatment termination (17).
A subsequent study conducted in Iran found behavioral activation superior to antidepressant medications (albeit at about half the maximum dosage) (18), and another in the United Kingdom found it superior to treatment as usual (19). Trials are currently under way comparing behavioral activation to CBT in primary care settings in the United Kingdom (20) and rural India (21), and an as yet unpublished trial indicates that behavioral activation reduced depressive symptoms with no risk of side effects for women given antenatal diagnoses of depression (personal communication, Dimidjian S, November 29, 2015).
Behavioral activation appears to be less complicated to learn than CBT, and if its apparent enduring effect proves to be robust, it may supplant that more established intervention. It is possible to train nonspecialist nurses to deliver behavioral activation (19), and as with CBT, it can be successfully delivered in both high-intensity and low-intensity ways (22, 23). Again, there is an increasing focus on delivering behavioral activation approaches in low-intensity ways via the use of worksheets, books, and online therapies, with high success.

Mindfulness-Based Cognitive Therapy (MBCT)

MBCT involves an integration of meditation training with cognitive therapy that is often provided in a group format. MBCT is well established as a preventive intervention and is often provided to patients who have first been brought to remission with antidepressant medications or other interventions (24). MBCT is currently recommended to prevent relapse in people who have had two or more episodes of depression; however, there is a lack of evidence on whether mindfulness approaches can aid in the treatment of milder depression or anxiety. MBCT’s mindfulness component may carry less stigma than conventional psychosocial interventions, and it may prove to be of particular use in reducing risk for pre- and postpartum depression among pregnant women who prefer not to take medications (25). Despite earlier misgivings, recent trials suggest that MBCT also might be efficacious in the treatment of acute depression (26) and that it can be used to prevent the onset of depression among at least some at-risk adolescents (27). However, again there have been difficulties involved in delivering the approach effectively in everyday settings—that is, when it is delivered without clarity of training, consistent delivery, and adequate supervision, and short follow-up times have been an issue for many studies (28, 29).

Acceptance and Commitment Therapy

Acceptance and commitment therapy is one of the newer “third wave” behavior therapies (along with behavioral activation and MBCT) that emphasize context and experiential aspects of psychological experience. It was developed to focus more on complicated long-standing treatment-resistant disorders and has not been as often applied to patients with diagnosed depressions, although change in the symptoms of depression often has been assessed across time. A recent meta-analysis found nearly 40 trials that assessed depression across the course of treatment in samples with a variety of different disorders; in those trials, acceptance and commitment therapy produced large within-group reductions in symptoms and moderate reductions relative to minimal treatment controls (but not active controls) (30). For example, only one study (conducted in Iran) focused on the treatment of patients who met criteria for major depressive disorders, and cell sizes in that trial were quite small (31). Although acceptance and commitment therapy has not been studied as much as the other interventions for diagnosed depression, the available findings indicate it shows promise with respect to efficacy, if not specificity.

Interpersonal Psychotherapy

Until recent years, IPT had one of the most consistent records of efficacy in controlled trials, demonstrating both efficacy and specificity across a number of trials (32). That may be partly because it has not been all that widely adopted and because most of the controlled trials were thus conducted by advocates expert in its implementation. That situation has changed somewhat in recent years. A trial coming out of New Zealand found that IPT was less efficacious than CBT in the treatment of patients with more severe depressions (33) or personality disorders (34), and another trial done in Canada found IPT less efficacious than antidepressant medications (35). On the other hand, an even more recent trial from the Netherlands found no differences between IPT and CBT (36), with indications of differential response (moderation) on the part of different patients (37). At this time it seems fair to say that IPT remains one of the best established treatments for depression, although it is still not widely practiced outside of certain areas.

Dynamic Psychotherapy

Dynamic psychotherapy remains one of the most widely practiced but least evaluated psychosocial interventions. In the past decade there has been an increased emphasis on brief interventions, often on those approaches characterized by adherence to treatment manuals and focused goals. There have been two recent trials worth noting. In the first, the effects of supportive-expressive therapy, a form of brief dynamic psychotherapy, did not differ from those of antidepressant medications (sertraline with nonresponders switched to venlafaxine at midtreatment) or placebo across 16 weeks of treatment (38). Within the larger sample, black men did better in supportive-expressive therapy than they did in either of the two pill conditions, and white women did better in either active intervention than they did in the placebo condition. In a separate trial conducted in the Netherlands, short-term dynamic psychotherapy did not differ from CBT, showing noninferiority to CBT for the continuous measures of depression but not for the somewhat disappointingly low categorical remission rates (22.7% overall) (39). It is not clear what conclusions can be drawn from these studies. On the one hand, dynamic psychotherapy was not inferior to two of the best-established interventions in the field (antidepressant medications and CBT), but on the other hand, in what were essentially null findings, neither study demonstrated either efficacy or specificity for dynamic psychotherapy. If dynamic psychotherapy were a novel medication, the U.S. Food and Drug Administration (FDA) would not have counted either study’s results as a positive indication sufficient for marketing. The first trial did include a nonspecific control condition, but antidepressant medications only exceeded placebo in about half the trials submitted to the FDA to win marketing approval for more recent serotonergic medications (40), and in the second trial, CBT was conducted by a group with no prior track record with that approach. Neither consideration inspires confidence in the generalizability of the comparisons.

Features of Evidence-Based High-Intensity Interventions

In summary, evidence-based interventions typically share three characteristics: They have a clear structure, focus on problems relevant to the person, and build on a relationship with a practitioner. This relationship has traditionally been extensive in terms of time and frequency of sessions (up to one-hour sessions for 12–20 weeks). A typical mindfulness course recommends 26 hours of therapy (29), and over 20 hours of CBT have been recommended for treatment-resistant depression (41). However, can a proportion of people recover equally well with shorter and more focused interventions?

Established Low-Intensity Interventions and Features

The challenge in offering clinical services is often how best to offer an effective intervention that is evidence based, well delivered, and cost-effective. In paid-for settings, when the number of sessions is often limited, it becomes especially important to test interventions that can be delivered in shorter, more focused ways and with less practitioner time overall—hence their labeling as low-intensity interventions in contrast to the high-intensity (longer) traditional ways of delivering therapies. Bennett-Levy et al. (42) provided an overview of the low-intensity approaches. Three key components are emphasized in low-intensity delivery: therapeutic model, modality of delivery, and amount and type of support.

Therapeutic Model

Low-intensity approaches have been developed and tested across an increasing range of disorders, including depression, anxiety, panic, and pain and fatigue. The majority of evaluated interventions to date have used CBT, reflecting its structured approach and psychoeducational skills-based content, which make it especially appropriate for low-intensity delivery. Increasingly, MBCT, acceptance and commitment therapy, and behavioral activation approaches also are becoming available via low-intensity interventions. Other approaches like brief psychodynamic therapy also can be delivered in this way (43). CBT-based resources (both book and online) are more effective at treating depression than are approaches using psychoeducation alone (44).

Modality of Delivery

Low-intensity delivery has at its heart the concept that resource materials deliver key components of the therapy. This might include delivery via print (bibliotherapy) and digital (computerized CBT, or cCBT) media. Both approaches lead to equivalent outcomes (44). Online approaches can provide scalability to encompass a large number of people; also, members of the public are more likely to endorse computer-oriented approaches than book-based approaches, and both are viewed more positively when offered with therapist support (i.e., as guided self-help) than when unsupported (unguided) (45). Some wider issues are also important when choosing which resources to use. Both books and online resources vary significantly in terms of accessibility and readability, and the typical reading ability required for bibliotherapy approaches excludes significant numbers of potential readers (46). It has been suggested that a learning assessment should be conducted in addition to the clinical assessment to identify choice of low-intensity resources (47).

Amount and Type of Support

For depression, the efficacy of CBT-based (self-help) resources improves significantly when accompanied by support from a practitioner. It appears this support can be delivered effectively by either experts or nonexperts in CBT, and the focus of the support does not need to include additional therapy components (44). Support contacts play a key role in helping encourage and motivate the patient to use the resources and overcome blocks and low motivation in applying what is learned. It appears there is no difference in outcome when support is delivered face to face or by telephone. Online support (e-mail or chat) is likely to be as efficacious. It is uncertain whether text-message–based chat is as effective, although it may have a role in reminding users to read or test out resources.

Do Low-Intensity Interventions Work?

An overview of studies suggests that computer-delivered and book-delivered CBTs appear equally effective and that modality selection should be informed by patient choice (44). A review of studies comparing low- and high-intensity interventions found equivalent outcomes in both the short term and the longer term (48). There are many uncertainties, however, and a recent large, well-conducted study with an active control group found no advantage of cCBT (free or licensed) over general practitioner usual care (49). However, that study provided little in the way of active support for the treatment packages, which perhaps explains the result.

Who Provides the Support?

A key issue in determining whether low-intensity interventions are working is whether fidelity to the underlying evidence-based model can be attained. Critics question whether such approaches provide only an inexpensive and poorer-quality form of service delivery. This criticism is not borne out by the data or by national treatment guidelines. Second, it is not fully clear whether some subgroups of people do better with more flexible support from a skilled and trained practitioner than from a generic support worker. In practice, at least in the United Kingdom, a majority of accredited CBT (high-intensity) specialists also supplement their work with self-help resources (50). Trials are needed to clarify whether this added expertise and knowledge of the CBT model lead to improved patient outcomes. Provisional data (44) suggest that they do not; however, this review examined the combined results of studies rather than identifying whether specific groups of patients (e.g., those with more complex or chronic presentations) required added input.

Which Patients Do Well or Poorly With Low-Intensity Approaches?

Many clinicians view CBT-based resources such as cCBT as being less effective than seeing a specialist practitioner (51). They identify patients who might do well with cCBT as those with milder presenting symptoms. This view is not supported by findings that show larger benefits in clinical samples than in samples of those who are less unwell (44). Also, severity did not predict who failed to engage with or benefit from low-intensity interventions (45). It is also unclear whether age affects outcomes.

Conclusions

Evidence-based psychological therapies are at an interesting stage. The evidence base for traditionally delivered high-intensity interventions is now established, reflecting benefits comparable to those of antidepressant medications across acute treatment and a long-term enduring effect (at least for CBT and possibly for behavioral activation) not found for medications. Attention has turned to whether similar benefits can be gained by delivering the same interventions in a shorter term and in more focused ways. A growing evidence base suggests that at least for CBT and behavioral activation, low-intensity interventions can be delivered effectively. However, for both high- and low-intensity interventions, the challenge is now to translate the good results found in well-controlled, treatment-manual–adherent, and supervised clinical trials into everyday clinical services. Much more needs to be known about patient preference, how to engage people in ways they want to work, and how to offer an approach that is consistently delivered in high-quality ways in order to maximize outcomes.

References

1.
Hollon SD, Areán PA, Craske MG, et al: Development of clinical practice guidelines. Annu Rev Clin Psychol 2014; 10:213–241
2.
Wampold BE: The Great Psychotherapy Debate: Models, Methods, and Findings. Mahwah, NJ, Erlbaum, 2001
3.
Luborsky L, Diguer L, Seligman DA, et al: The researcher’s own therapy allegiances: a “wild card” in comparisons of treatment efficacy. Clin Psychol Sci Pract 1999; 6:95–106
4.
Hollon SD: The efficacy and effectiveness of psychotherapy relative to medications. Am Psychol 1996; 51:1025–1030
5.
Cuijpers P, Driessen E, Hollon SD et al: The efficacy of non-directive supportive therapy for adult depression: a meta-analysis. Clin Psychol Rev 2012; 32:280–291
6.
Hollon SD: Cognitive and behavior therapy in the treatment and prevention of depression. Depress Anxiety 2011; 28:263–266
7.
DeRubeis RJ, Hollon SD, Amsterdam JD et al: Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry 2005; 62:409–416
8.
Weitz ES, Hollon SD, Twisk J, et al: Does baseline depression severity moderate depression outcomes between CBT versus pharmacotherapy? An individual patient data meta-analysis. JAMA Psychiatry (Epub September 23, 2015). Available at
9.
Hollon SD, DeRubeis RJ, Shelton RC, et al: Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry 2005; 62:417–422
10.
Cuijpers P, Hollon SD, van Straten A, et al: Does cognitive behavior therapy have an enduring effect that is superior to keeping patients on continuation pharmacotherapy? BMJ Open 2013; 3:e002542. Available at
11.
Hollon SD, DeRubeis RJ, Fawcett J, et al: Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. JAMA Psychiatry 2014; 71:1157–1164
12.
DeRubeis RJ, Cohen ZD, Forand NR, et al: The Personalized Advantage Index: translating research on prediction into individualized treatment recommendations: a demonstration. PLoS One 2014; 9:e83875. Available at
13.
Depression: The Treatment and Management of Depression in Adults. London, National Institute for Clinical Excellence, 2009
14.
Clark DM, Layard R, Smithies R, et al: Improving access to psychological therapy: initial evaluation of two UK demonstration sites. Behav Res Ther 2009; 47:910–920
15.
Skinner BF: Beyond Freedom and Dignity. New York, Knopf, 1971
16.
Dimidjian S, Hollon SD, Dobson KS, et al: Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of major depression. J Consult Clin Psychol 2006; 74:658–670
17.
Dobson KS, Hollon SD, Dimidjian S, et al: Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression. J Consult Clin Psychol 2008; 76:468–477
18.
Moradveisi L, Huibers MJH, Renner F et al: Behavioural activation v antidepressant medication for treating depression in Iran: randomised trial. Br J Psychiatry 2013; 202:204–211
19.
Ekers D, Richards D, McMillan D, et al: Behavioural activation delivered by the non-specialist: phase II randomised controlled trial. Br J Psychiatry 2011; 198:66–72
20.
Rhodes S, Richards DA, Ekers D, et al: Cost and outcome of behavioural activation versus cognitive behaviour therapy for depression (COBRA): study protocol for a randomised controlled trial. Trials 2014; 15:29
21.
Patel V, Weobong B, Nadkarni A, et al: The effectiveness and cost-effectiveness of lay counsellor-delivered psychological treatments for harmful and dependent drinking and moderate to severe depression in primary care in India: PREMIUM study protocol for randomized controlled trials. Trials 2014; 15:101
22.
Lejuez CW, Hopko DR, Hopko SD: The Brief Behavioural Activation Treatment for Depression: A Comprehensive Patient Guide. Boston, Pearson Custom, 2003
23.
Martell CR, Addis ME, Jacobson NS: Depression in Context: Strategies for Guided Action. New York, Norton, 2001
24.
Piet J, Hougaard E: The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: a systematic review and meta-analysis. Clin Psychol Rev 2011; 31:1032–1040
25.
Dimidjian S, Goodman SH, Felder JN, et al: Staying well during pregnancy and the postpartum: a pilot randomized trial of mindfulness-based cognitive therapy for the prevention of depressive relapse/recurrence. J Consult Clin Psychol (Epub December 14, 2015)
26.
Strauss C, Cavanagh K, Oliver A, et al: Mindfulness-based interventions for people diagnosed with a current episode of an anxiety or depressive disorder: a meta-analysis of randomised controlled trials. PLoS One 2014; 9:e96110. Available at
27.
Kallapiran K, Koo S, Kirubakaran R, et al: Review: Effectiveness of mindfulness in improving mental health symptoms of children and adolescents: a meta-analysis. Child Adolesc Ment Health 2015; 20:182–194
28.
Sundquist J, Lilja Å, Palmér K, et al: Mindfulness group therapy in primary care patients with depression, anxiety and stress and adjustment disorders: randomised controlled trial. Br J Psychiatry 2015; 206:128–135
29.
Williams C, Mercer S: Can mindfulness groups treat common mental health problems? Problematic design and short follow-up fails to answer the question. Evid Based Ment Health. (Epub October 12, 2015). Available at
30.
Hacker T, Stone P, MacBeth A: Acceptance and commitment therapy - do we know enough? Cumulative and sequential meta-analyses of randomized controlled trials. J Affect Disord 2016; 190:551–565
31.
Tamannaeifar S, Gharraee B, Birashk B, et al: A comparative effectiveness of acceptance and commitment therapy and group cognitive therapy for major depressive disorder. Zahedan J Res Med Sci 2014; 16:60–63
32.
Hollon SD, Ponniah K: A review of empirically supported psychological therapies for mood disorders in adults. Depress Anxiety 2010; 27:891–932
33.
Luty SE, Carter JD, McKenzie JM, et al: Randomised controlled trial of interpersonal psychotherapy and cognitive-behavioural therapy for depression. Br J Psychiatry 2007; 190:496–502
34.
Joyce PR, McKenzie JM, Carter JD, et al: Temperament, character and personality disorders as predictors of response to interpersonal psychotherapy and cognitive-behavioural therapy for depression. Br J Psychiatry 2007; 190:503–508
35.
Marshall MB, Zuroff DC, McBride C, et al: Self-criticism predicts differential response to treatment for major depression. J Clin Psychol 2008; 64:231–244
36.
Lemmens LHJM, Arntz A, Peeters F, et al: Clinical effectiveness of cognitive therapy v interpersonal psychotherapy for depression: results of a randomized controlled trial. Psychol Med 2015; 1–16
37.
Huibers MJH, Cohen ZD, Lemmens LHJM, et al: Predicting optimal outcomes in cognitive therapy or interpersonal psychotherapy for depressed individuals using the personalized advantage index approach. PLoS One 2015; 10:e0140771. Available at
38.
Barber JP, Barrett MS, Gallop R, et al: Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial. J Clin Psychiatry 2012; 73:66–73
39.
Driessen E, Van HL, Don FJ, et al: The efficacy of cognitive-behavioral therapy and psychodynamic therapy in the outpatient treatment of major depression: a randomized clinical trial. Am J Psychiatry 2013; 170:1041–1050
40.
Turner EH, Matthews AM, Linardatos E, et al: Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008; 358:252–260
41.
Wiles N, Thomas L, Abel A, et al: Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial. Lancet 2013; 381:375–384. Available at
42.
Bennett-Levy J, Richards DA, Farrand P, et al. (eds): The Oxford Guide to Low Intensity CBT Interventions. Oxford, Oxford University Press, 2010
43.
Lewis G, Anderson L, Araya R, et al: Self-Help Interventions for Mental Health Problems. Report to the Department of Health R and D Programme, London, National Institute for Mental Health in England, 2003. Available at www.nimhe.org.uk/downloads/self_help.pdf
44.
Gellatly J, Bower P, Hennessy S, et al: What makes self-help interventions effective in the management of depressive symptoms? Meta-analysis and meta-regression. Psychol Med 2007; 37:1217–1228
45.
Hanson K, Webb TL, Sheeran, P, et al: Attitudes and preferences towards self-help treatments for depression in comparison to psychotherapy and antidepressant medication. Behav Cogn Psychother (Epub February 20, 2015). Available at
46.
Martinez R, Whitfield G, Dafters R, et al: Can people read self-help manuals for depression? A challenge for the stepped care model and book prescription schemes. Behav Cogn Psychother 2008; 36:89–97
47.
Williams C, Morrison J: A new language for CBT: new ways of working require new thinking as well as new words; in Oxford Guide to Low Intensity CBT Interventions. Edited by Bennett-Levy J, Richards D, Farrand P et al. Oxford, Oxford University Press, 2010, pp 69–83
48.
Cuijpers P, Donker T, van Straten A et al: Is guided self-help as effective as face-to-face psychotherapy for depression and anxiety disorders? A systematic review and meta-analysis of comparative outcome studies. Psychol Med 2010; 40:1943–1957
49.
Gilbody, S, Littlewood, E, Hewitt, E et al: Computerised cognitive behaviour therapy (cCBT) as treatment for depression in primary care (REEACT trial): large scale pragmatic randomised controlled trial. BMJ (Epub November 11, 2015). Available at
50.
Keeley H, Williams CJ, Shapiro D: A United Kingdom survey of accredited cognitive behaviour therapists’ attitudes towards and use of structured self-help materials. Behav Cogn Psychother 2002; 30:191–201
51.
Whitfield G, Williams CJ: If the evidence is so good why doesn’t anyone use them? Current uses of computer-based self-help packages. Behav Cogn Psychother 2004; 32:57–65

Information & Authors

Information

Published In

History

Published in print: Spring 2016
Published online: 13 April 2016

Authors

Details

Steven D. Hollon, Ph.D.
Dr. Hollon is with the Department of Psychology, Vanderbilt University, Nashville, Tennessee (e-mail: [email protected]). Dr. Williams is with the Department of Psychosocial Psychiatry, Institute of Health and Wellbeing, University of Glasgow, Glasgow, Scotland, and president of the British Association for Behavioural and Cognitive Psychotherapies.
Christopher J. Williams, M.D.
Dr. Hollon is with the Department of Psychology, Vanderbilt University, Nashville, Tennessee (e-mail: [email protected]). Dr. Williams is with the Department of Psychosocial Psychiatry, Institute of Health and Wellbeing, University of Glasgow, Glasgow, Scotland, and president of the British Association for Behavioural and Cognitive Psychotherapies.

Funding Information

Dr. Williams receives royalties from, and is a shareholder and director of, a cognitive-behavioral therapy resource publishing company. Dr. Hollon reports no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Focus

PPV Articles - Focus

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share